Imatinib-induced pancreatitis
- PMID: 20606838
- PMCID: PMC2885641
- DOI: 10.4103/0253-7613.62407
Imatinib-induced pancreatitis
Abstract
Drug-induced pancreatitis is a rare but serious complication of many drugs, some of which have been well documented. Here we present a case of a middle-aged man with chronic myeloid leukemia who developed acute pancreatitis after being initiated on imatinib mesylate. The case history, the pharmacodynamics, uses, and adverse effects of imatinib mesylate are discussed in detail.
Keywords: Acute pancreatitis; chronic myeloid leukemia; imatinib mesylate.
Figures
References
-
- Forsmark CE, Baillie J AGA Institute Clinical Practice and Economics Committee, AGA Institute Governing Board. AGA Institute technical review on acute pancreatitis. Gastroenterology. 2007;132:2022–44. - PubMed
-
- Levy P, Mathurin P, Roqueplo A, Rueff B, Bernades P. A multidimensional case-control study of dietary, alcohol, and tobacco habits in alcoholic men with chronic pancreatitis. Pancreas. 1995;10:231–8. - PubMed
-
- Naranjo C, Busto U, Sellers EM, Sandor P, Ruiz I, Roberts EA, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther. 1981;30:239–45. - PubMed
-
- Yanada M, Takeuchi J, Sugiura I, Akiyama H, Usui N, Yagasaki F, et al. High complete remission rate and promising outcome by combination of imatinib and chemotherapy for newly diagnosed BCR-ABL-positive acute lymphoblastic leukemia: A phase II study by the Japan Adult Leukemia Study Group. J Clin Oncol. 2006;24:460–6. - PubMed
-
- Greenberger NJ, Toskes PP. Acute and chronic pancreatitis. Harrison's Online. Available from: http://www.accessmedicine.com. [accessed on 2006 May 31] - PubMed
LinkOut - more resources
Full Text Sources
